Eshelman Ventures
Overview
Eshelman Ventures is an investment company primarily interested in healthcare companies. The firm was founded by Fred Eshelman, who previously founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests. Although Eshelman Ventures concentrates in healthcare, the firm will consider other themes that are attractive and have large potential markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pacegenix | Mar 2026 | Early Stage VC | Co-investor |
| Incyclix Bio | Apr 2026 | Series B Extension | Co-investor |
| Komo Biosciences | Jul 2024 | Seed | Co-investor |
| Breakthru Medicine | Jan 2026 | Series A | Co-investor |
| Dignify Therapeutics | Feb 2015 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Eshelman Ventures based?
Eshelman Ventures is headquartered in Wilmington, North Carolina, United States.
When was Eshelman Ventures founded?
Eshelman Ventures was founded in 2014.
How many portfolio companies does Eshelman Ventures have?
Eshelman Ventures has 9 portfolio companies in Caplight's dataset.
What are some companies in Eshelman Ventures's portfolio?
Portfolio companies visible on Caplight include Pacegenix, Incyclix Bio, Komo Biosciences, Breakthru Medicine, Dignify Therapeutics.
What was Eshelman Ventures's most recent investment shown here?
Eshelman Ventures's most recent investment in this portfolio sample was in Incyclix Bio in 2026.
What sectors does Eshelman Ventures focus on?
Eshelman Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Eshelman Ventures focus on?
Eshelman Ventures typically invests at the Mid stage.
What is Eshelman Ventures's AUM?
Eshelman Ventures's assets under management are estimated between $0.0 and $50.0M.